Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain

Inclusion Criteria: * Male or female ≥ \[greater than or equal to\] 40 years of age * If a participant in the previous DIC3-08-05 study, completed the study and did not discontinue for lack of efficacy or safety * Has a diagnosis of OA of the hip or knee with ongoing knee and/or articular hip pain * Is a current chronic user of nonsteroidal anti-inflammatory drugs (NSAIDs) and/or acetaminophen for his/her OA pain and is anticipated to benefit from continuous treatment with therapeutic doses of NSAIDs. A current chronic user is defined as a subject who has used these treatments for ≥ \[greater than or equal to\] 20 days of the last 30 days before screening Exclusion Criteria: * Has a known history of allergic reaction or clinically significant intolerance to acetaminophen, aspirin, or any nonsteroid anti-inflammatory drugs (NSAIDs), including diclofenac * Requires chronic use of opioid or opioid combination products to control OA pain of the knee or hip * Has any clinically significant unstable cardiac, respiratory, neurological, immunological, hematological, or renal disease * Has significant difficulties swallowing capsules or is unable to tolerate oral medication